Does Charles River Laboratories (CRL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 2.6% in the afternoon session after the stock's positive momentum continued, as Barclays upgraded the company to Overweight ...

Lab services company Charles River Laboratories (NYSE:CRL) announced in Q3 CY2025, but sales were flat year on year at $1.00 billion. Its non-GAAP profit of $2.43 per share was 3.9% above analysts’ ...

Charles River Laboratories International, Inc. CRL has introduced Apollo for CRADL (Charles River Accelerator and Development Lab), a secure cloud-based platform that enhances leading vivarium rental ...

Charles River Laboratories International, Inc. CRL is scheduled to report third-quarter 2024 results on Nov. 6, before market open. In the last reported quarter, the company’s adjusted earnings per ...

Detailed price information for Charles River Laboratories (CRL-N) from The Globe and Mail including charting and trades.

Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...

About Charles River Laboratories International Inc. Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It ...